a public good project by the
Synthesis
Company
of California

© 2026

Yurong Qiu | doi.page

0 works0 citations0 h-index

Yurong Qiu

Shanghai Huayi Group (China)(CN)Southern Medical University(CN)Guangzhou Medical University(CN)

Publications by Year

Research Areas

Systemic Lupus Erythematosus Research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Immune Cell Function and Interaction

Most-Cited Works

→ Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus(2019)216 cited
→ Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus(2019)94 cited
→ Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus(2020)66 cited
→ Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy(2016)38 cited
→ Dihydrocapsaicin Attenuates Plaque Formation through a PPARγ/LXRα Pathway in apoE−/− Mice Fed a High-Fat/High-Cholesterol Diet(2013)37 cited
→ IL-17 and IL-21 polymorphisms in relation to HBV related hepatocellular carcinoma in Chinese Han population(2020)18 cited

→ Evaluation of the Elecsys syphilis immunoassay for routine screening of serum samples in China(2017)

13 cited

→ Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy(2019)11 cited

→ Reflex threshold of signal-to-cut-off ratios of the Elecsys anti-HCV II assay for hepatitis C virus infection(2016)10 cited

Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.(2002)